Serum 25‐hydroxyvitamin D, vitamin D‐related variants, and risk of chronic liver disease
International Journal of Cancer · 2025-11 · 157 (9) · 1781-1794
DOI: 10.1002/ijc.35522 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 14.06.2025. Verfasst von Qian Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics and Ministry of Education Key Lab of Environment and Health, School of Public Health, Tongji Medical Col…. Hauptthemen laut MEDLINE: Vitamin D, Vitamin D-Binding Protein, Receptors, Calcitriol, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Young Top-notch Talent Cultivation Program of Hubei Province.
Abstract (Originalsprache)
The associations of serum 25‐hydroxyvitamin D (25(OH)D) with cirrhosis and liver cancer have not been well examined. It remained unclear whether functional vitamin D‐related variants modify these associations. During follow‐up of 401,551 UK Biobank participants with valid 25(OH)D data, we documented 4404 incident non‐alcoholic fatty liver disease (NAFLD), 1989 incident cirrhosis, and 480 incident liver cancer. The binding affinity values of 25(OH)D to vitamin D binding protein (VDBP) were estimated based on combinations of VDBP variants rs4588 and rs7041. Vitamin D receptor (VDR) activity was calculated by summing the number of related alleles for rs11568820, rs2228570, and rs1544410. Hazard ratio (95% confidence intervals) for serum 25(OH)D of ≥50 nmol/L (vs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics and Ministry of Education Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, Chi…
- Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Cancer Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Organ Transplantation Clinical Medical Research Center of Hubei Province, Wuhan, Hubei, China.
ORCID-Profile: Xia Sheng, Jiang Chang, Xuehong Zhang, Rong Zhong
Förderung
- National Natural Science Foundation of China
- Young Top-notch Talent Cultivation Program of Hubei Province
Zitieren
APA
Shen, Q., Shi, S., Wang, H., Zhang, S., Qin, S., Sheng, X., Chang, J., Zhang, X., Cheng, X., & Zhong, R. (2025). Serum 25‐hydroxyvitamin D, vitamin D‐related variants, and risk of chronic liver disease. International Journal of Cancer, 157(9), 1781-1794. https://doi.org/10.1002/ijc.35522
Vancouver
Shen Q, Shi S, Wang H, Zhang S, Qin S, Sheng X, et al. Serum 25‐hydroxyvitamin D, vitamin D‐related variants, and risk of chronic liver disease. International Journal of Cancer. 2025;157(9):1781-1794. doi:10.1002/ijc.35522
BibTeX
@article{Shen2025,
author = {Shen, Qian and Shi, Shanshan and Wang, Haoxue and Zhang, Shanshan and Qin, Shifan and Sheng, Xia and Chang, Jiang and Zhang, Xuehong and Cheng, Xiang and Zhong, Rong},
title = {Serum 25‐hydroxyvitamin D, vitamin D‐related variants, and risk of chronic liver disease},
journal = {International Journal of Cancer},
year = {2025},
volume = {157},
number = {9},
pages = {1781--1794},
doi = {10.1002/ijc.35522}
}
EUVIMED